Skip to main content
Premium Trial:

Request an Annual Quote

BioFocus to Collaborate with Cellectricon

NEW YORK (GenomeWeb News) – Swedish biotech company Cellectricon announced today that contract research organization BioFocus DPI will use its automated patch clamp system, called Dynaflow, in its electrophysiology-based screening programs.

Under the agreement, BioFocus plans to use Cellectricon's high-throughput microfluidic screening platform to improve its research on fast ligand-gated ion channels screening and other ion channel drug discovery approaches. BioFocus VP of Biological Sciences Kate Hilyard said in a statement that the collaboration is expected to help BioFocus increase its throughput and the number of ion channel subtypes it screens.

Financial terms of the agreement were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.